[go: up one dir, main page]

CL2016000822A1 - Cancer treatment with a combination of plinabulin and taxane - Google Patents

Cancer treatment with a combination of plinabulin and taxane

Info

Publication number
CL2016000822A1
CL2016000822A1 CL2016000822A CL2016000822A CL2016000822A1 CL 2016000822 A1 CL2016000822 A1 CL 2016000822A1 CL 2016000822 A CL2016000822 A CL 2016000822A CL 2016000822 A CL2016000822 A CL 2016000822A CL 2016000822 A1 CL2016000822 A1 CL 2016000822A1
Authority
CL
Chile
Prior art keywords
plinabulin
combination
taxane
cancer treatment
treatment
Prior art date
Application number
CL2016000822A
Other languages
Spanish (es)
Inventor
Lan Huang
Original Assignee
Beyondspring Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=59858232&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2016000822(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beyondspring Inc filed Critical Beyondspring Inc
Priority to CL2016000822A priority Critical patent/CL2016000822A1/en
Publication of CL2016000822A1 publication Critical patent/CL2016000822A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

USO DE PLINABULINA EN EL TRATAMIENTO DE NEUTROPENIA INDUCIDA POR TAXANO; COMBINACION FARMACEUTICA.USE OF PLINABULIN IN THE TREATMENT OF NEUTROPENIA INDUCED BY TAXAN; PHARMACEUTICAL COMBINATION

CL2016000822A 2016-04-08 2016-04-08 Cancer treatment with a combination of plinabulin and taxane CL2016000822A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CL2016000822A CL2016000822A1 (en) 2016-04-08 2016-04-08 Cancer treatment with a combination of plinabulin and taxane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2016000822A CL2016000822A1 (en) 2016-04-08 2016-04-08 Cancer treatment with a combination of plinabulin and taxane

Publications (1)

Publication Number Publication Date
CL2016000822A1 true CL2016000822A1 (en) 2016-12-02

Family

ID=59858232

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2016000822A CL2016000822A1 (en) 2016-04-08 2016-04-08 Cancer treatment with a combination of plinabulin and taxane

Country Status (1)

Country Link
CL (1) CL2016000822A1 (en)

Similar Documents

Publication Publication Date Title
CL2016001609A1 (en) Pharmaceutical compositions comprising azd9291.
CL2016002027A1 (en) Cyclopropylamine as an inhibitor of lsd1
CL2016002269A1 (en) Allosteric modulators of the hepatitis core protein b.
CL2016001840A1 (en) Compounds derived from fused pyrimidines as inhibitors of the p97 complex; Pharmaceutical composition and use in cancer treatment.
CL2016000807A1 (en) Amino heteroaryl benzamides as kinase inhibitors.
CL2016002971A1 (en) Combination.
CL2015002472A1 (en) As inhibitors of mutant idh-yl-oxazolidin-2-ones 3-pyrimidin-4.
MX2017001512A (en) Compounds active towards bromodomains.
UY36075A (en) TUBULISINE DERIVATIVES
CL2015001985A1 (en) Thiazolcarboxamides and pyridinecarboxamide compounds, pim kinase inhibitors.
MX2015010312A (en) METHODS FOR TREATMENT OF MELANOMA.
CR20160367A (en) FUSED HETEROCYCLIC COMPOUND
CL2018003444A1 (en) Adenosine derivatives for use in the treatment of cancer.
AR104664A1 (en) CONJUGATES OF DRUGS WITH ANTIBODIES AGAINST CADHERINE 6 (ANTI-CDH6)
CL2016001743A1 (en) Antibody-drug (adc) conjugates of duocarmycin for use in the treatment of endometrial cancer.
TWD168487S (en) Cufflink
CL2016003260A1 (en) Gemcitabine prodrugs
CL2015002180A1 (en) Combination therapy for the treatment of nosocomial pneumonia
CL2015002897A1 (en) Bace1 inhibitors
CL2016002835A1 (en) "Compounds derived from pladienolide with a pyridinic moiety; pharmaceutical composition comprising them; and its use in cancer treatment. ” pct
DOP2017000111A (en) AURORA CINASA INHIBITOR A
CL2015003019A1 (en) Biaromatic antibacterial derivatives
CL2018002793A1 (en) Cancer therapy with an oncolytic virus combined with a control point inhibitor
HRP20181490T1 (en) COMPOUNDS 1, 3, 4-THIADIAZOLE AND THEIR USE IN CANCER TREATMENT
CL2015001202A1 (en) Compounds derived from oxazolidin-2-one-pyrimidine; pharmaceutical composition and combination and use in the treatment of cancer.